Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

× No keyword cloud information.

7 in total

1. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Authors: Konstantinos Papamichael; Adam S Cheifetz; Gil Y Melmed; Peter M Irving; Niels Vande Casteele; Patricia L Kozuch; Laura E Raffals; Leonard Baidoo; Brian Bressler; Shane M Devlin; Jennifer Jones; Gilaad G Kaplan; Miles P Sparrow; Fernando S Velayos; Thomas Ullman; Corey A Siegel
Journal: Clin Gastroenterol Hepatol Date: 2019-03-27 Impact factor: 11.382

2. Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?

Authors: Konstantinos Papamichael; Adam S Cheifetz
Journal: Curr Opin Gastroenterol Date: 2019-07 Impact factor: 3.287

3. A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease.

Authors: José Germán Sánchez-Hernández; Noemí Rebollo; Ana Martin-Suarez; M Victoria Calvo; Fernando Muñoz
Journal: Br J Clin Pharmacol Date: 2020-02-21 Impact factor: 4.335

4. UK National Survey of Gastroenterologists' attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease.

Authors: Gaurav B Nigam; Shadab Nayeemuddin; Evangelos Kontopantelis; Bu'Hussain Hayee; Jimmy K Limdi
Journal: Frontline Gastroenterol Date: 2020-01-24

Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

1. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

2. Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?

3. A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease.

4. UK National Survey of Gastroenterologists' attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease.

Review 5. Biologic therapies for Crohn's disease: optimising the old and maximising the new.

6. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.

Review 7. Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases.